Segment, Geographical and Other Revenue Information (Tables)

3 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of segment reporting

The following table provides financial information by our reportable business segments along with a reconciliation to consolidated loss before income taxes (in thousands):

	Three months ended March 31, 2018								Three months ended March 31, 2017
	Performance Enzymes			Novel Biothera-peutics		Total			Performance Enzymes			Novel Biothera-peutics			Total
Revenues:
Product revenue	$	6,163		$	—	$	6,163		$	5,586		$	—		$	5,586
Research and development revenue	4,566			3,313		7,879			2,385			—			2,385
Total revenues	10,729			3,313		14,042			7,971			—			7,971
Costs and operating expenses:
Cost of product revenue	3,825			—		3,825			3,002			—			3,002
Research and development(1)	5,066			1,932		6,998			4,150			1,511			5,661
Selling, general and administrative	2,096			146		2,242			1,812			—			1,812
Total costs and operating expenses	10,987			2,078		13,065			8,964			1,511			10,475
Income (loss) from operations	$	(258	)	$	1,235	$	977		$	(993	)	$	(1,511	)	$	(2,504	)
Corporate costs (2)						(5,435		)							(4,606		)
Depreciation and amortization						(238		)							(326		)
Loss before income taxes						$	(4,696	)							$	(7,436	)

⁽¹⁾ Research and development expenses exclude depreciation and amortization.

⁽²⁾ Corporate costs include unallocated selling, general and administrative expense, interest income, and other income and expenses.

The following table provides stock-based compensation expense included in income (loss) from operations by segment (in thousands):

	Three months ended March 31, 2018						Three months ended March 31, 2017
	Performance Enzymes		Novel Biothera-peutics		Total		Performance Enzymes		Novel Biothera-peutics		Total
Stock-based compensation	$	333	$	63	$	396	$	221	$	52	$	273

Schedule of customers that contributed 10% or more of total accounts receivable

Customers that each contributed 10% or more of our total revenues were as follows:

	Percentage of Total Revenues for the
	Three Months Ended March 31,
	2018	2017
Customer A	48%	38%
Customer B	*	20%
Customer C	*	19%
Customer D	24%	*
Customer E	10%	*

Customers that each contributed 10% or more of our total accounts receivable had the following balances as of the periods presented:

	Percentage of Accounts Receivables at
	March 31, 2018	December 31, 2017
Customer A	46%	31%
Customer C	12%	15%
Customer E	*	16%
Customer F	13%	14%

* Less than 10% of the period presented

Schedule of revenues by geographical area

Geographic revenues are identified by the location of the customer and consist of the following (in thousands):

	Three Months Ended March 31,
	2018		2017
Revenues
Americas	$	3,597	$	1,788
EMEA	4,992		3,208
APAC	5,453		2,975
Total revenues	$	14,042	$	7,971

Schedule of long-lived assets by geographical area

Identifiable long-lived assets as follows (in percentage):

Long-lived assets:	March 31, 2018		December 31, 2017
United States	100	%	100	%